Literature DB >> 10330259

L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation.

T Ogura1, L M Shuba, T F McDonald.   

Abstract

Guinea pig ventricular myocytes in whole cell configuration were treated with tyrosine kinase (TK) inhibitors [genistein (Gst), tyrphostin A23 (T23), and tyrphostin A25 (T25)] and with inactive analogs [daidzein, genistin, and tyrphostin A1 (T1)] to measure effects on L-type Ca2+ current (ICa,L). Gst inhibited ICa,L (IC50 = 47 microM) without affecting its time course or shifting the ICa, L-voltage relationship. At the highest concentration of isoflavone tested (200 microM), ICa,L was inhibited by 66 +/- 7% (Gst), 22 +/- 2% (daidzein), and 1 +/- 3% (genistin). Inhibition of ICa,L by the active tyrphostins was significantly larger than inhibition by T1; at 200 microM the inhibitions were 72 +/- 6% (T23), 71 +/- 6% (T25), and 27 +/- 6% (T1). The phosphotyrosine phosphatase inhibitor orthovanadate (1 mM) had a small stimulatory effect (6 +/- 2%) on basal ICa,L and blocked the inhibition of ICa,L by TK inhibitors. The data suggest a role for the TK-phosphotyrosine phosphatase system in the regulation of cardiac Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330259     DOI: 10.1152/ajpheart.1999.276.5.H1724

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Inhibition of fast sodium current in rabbit ventricular myocytes by protein tyrosine kinase inhibitors.

Authors:  Yanggan Wang; Mary B Wagner; Rajiv Kumar; Jun Cheng; Ronald W Joyner
Journal:  Pflugers Arch       Date:  2003-04-26       Impact factor: 3.657

2.  Redox modulation of basal and beta-adrenergically stimulated cardiac L-type Ca(2+) channel activity by phenylarsine oxide.

Authors:  Carl Sims; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

3.  Effect of genistein on voltage-gated potassium channels in guinea pig proximal colon smooth muscle cells.

Authors:  Shi-Ying Li; Bin-Bin Huang; Shou Ouyang
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.

Authors:  Guo-Sheng Xiao; Yan-Hui Zhang; Wei Wu; Hai-Ying Sun; Yan Wang; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2017-02-09       Impact factor: 8.739

5.  Kinase-dependent activation of voltage-gated Ca2+ channels by ET-1 in pulmonary arterial myocytes during chronic hypoxia.

Authors:  Trevor Luke; Julie Maylor; Clark Undem; J T Sylvester; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

6.  Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium K(IR)2.3 channel, stably expressed in HEK 293 cells.

Authors:  De-Yong Zhang; Yan-Hui Zhang; Hai-Ying Sun; Chu-Pak Lau; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  PKD2 functions as an epidermal growth factor-activated plasma membrane channel.

Authors:  Rong Ma; Wei-Ping Li; Dana Rundle; Jin Kong; Hamid I Akbarali; Leonidas Tsiokas
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.

Authors:  Hee Jae Kim; Hye Sook Ahn; Bok Hee Choi; Sang June Hahn
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-09       Impact factor: 4.249

9.  Insensitivity of cardiac delayed-rectifier I(Kr) to tyrosine phosphorylation inhibitors and stimulators.

Authors:  Sergey Missan; Pavel Zhabyeyev; Paul Linsdell; Terence F McDonald
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

10.  Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes.

Authors:  Sergey Missan; Paul Linsdell; Terence F McDonald
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.